Comparative Diagnostic Value of Urine Cytology, UBC-ELISA, and Fluorescence In Situ Hybridization for Detection of Transitional Cell Carcinoma of Urinary Bladder in Routine Clinical Practice

Urology

Volumn 70, Issue 3, 2007, Pages 449-453

  May, Matthias ^a   Hakenberg, Oliver W ^b   Gunia, Sven ^a   Pohling, Peter ^a   Helke, Christian ^a   Lübbe, Lieselotte ^a   Nowack, Rudolf ^a   Siegsmund, Michael ^c   Hoschke, Bernd ^a  

^a Carl Thiem Hospital Cottbus   (Germany)

^b ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

^c VIVANTES KLINIKUM AM URBAN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CLINICAL PRACTICE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HISTOLOGY; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALIDITY; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; URINARY BLADDER CANCER TEST; URINE CYTOLOGY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CARCINOMA, TRANSITIONAL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KERATIN-18; KERATIN-8; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS; URINE;

EID: 34648840783     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.04.023     Document Type: Article

References (19)

1. Messing E.M. Urothelial tumors of the urinary tract. In: Walsh P.C., Retik A.B., Vaughan Jr. E.D., et al. (Eds). Campbell's Urology. 8th ed. (2002), WB Saunders, Philadelphia 2732-2784
2. Oosterlinck W., Lobel B., Jakse G., et al. Guidelines on bladder cancer. Eur Urol 41 (2002) 105-112
3. Glas A.S., Roos D., Deutekom M., et al. Tumor markers in the diagnosis of primary bladder cancer: a systematic review. J Urol 169 (2003) 1975-1982
4. van Rhijn B.W., van der Poel H.G., and van der Kwast T.H. Urine markers for bladder cancer surveillance: a systematic review. Eur Urol 47 (2005) 736-748
5. Placer J., Espinet B., Salido M., et al. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: a FISH study. Urology 65 (2005) 913-918
6. Mazzucchelli R., Barbisan F., Stramazzotti D., et al. Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features. Anal Quant Cytol Histol 27 (2005) 143-151
7. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 164 (2000) 1768-1775
8. Bubendorf L., Grilli B., Sauter G., et al. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 116 (2001) 79-86
9. Placer J., Espinet B., Salido M., et al. Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology. Eur Urol 42 (2002) 547-552
10. Sarosdy M.F., Schellhammer P., Bokinsky G., et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol 168 (2002) 1950-1954
11. Skacel M., Fahmy M., Brainard J.A., et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 169 (2003) 2101-2105
12. Bollmann M., Heller H., Bankfalvi A., et al. Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?. BJU Int 95 (2005) 1219-1225
13. Laudadio J., Keane T.E., Reeves H.M., et al. Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice. BJU Int 96 (2005) 1280-1285
14. Mungan N.A., Vriesema J.L., Thomas C.M., et al. Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer. Urology 56 (2000) 787-792
15. Giannopoulos A., Manousakas T., Gounari A., et al. Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors. J Urol 166 (2001) 470-475
16. Lubbe L., Nowack R., May M., et al. FISH-a new noninvasive method for the diagnosis of urinary bladder carcinomas. Clin Lab 50 (2004) 395-402
17. Epstein J.I., Amin M.B., Reuter V.R., et al., Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22 (1998) 1435-1448
18. Mostofi F.K., Davis C.J., and Sesterhenn I. WHO Histological Typing of Urinary Bladder Tumors. 2nd ed. (1999), Springer, Berlin
19. Hakenberg O.W., Fuessel S., Richter K., et al. Qualitative and quantitative assessment of urinary cytokeratin 8 and 18 fragments compared with voided urine cytology in diagnosis of bladder carcinoma. Urology 64 (2004) 1121-1126